PROCEEDINGS VOLUME 7886
SPIE BIOS | 22-27 JANUARY 2011
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX
IN THIS VOLUME

0 Sessions, 29 Papers, 0 Presentations
Front Matter  (1)
PDT Models  (3)
Proceedings Volume 7886 is from: Logo
SPIE BIOS
22-27 January 2011
San Francisco, California, United States
Front Matter
Proc. SPIE 7886, Front Matter: Volume 7886, 788601 (7 April 2011); doi: 10.1117/12.890764
Preclinical PDT I
Proc. SPIE 7886, Biological consequences of PDT: tying up the loose ends, 788602 (8 February 2011); doi: 10.1117/12.876209
Preclinical PDT II
Proc. SPIE 7886, Biologically relevant 3D tumor arrays: imaging-based methods for quantification of reproducible growth and analysis of treatment response, 788608 (28 February 2011); doi: 10.1117/12.876149
Proc. SPIE 7886, Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners, 788609 (2 March 2011); doi: 10.1117/12.875892
Proc. SPIE 7886, Determination of blood plasma fluorescence extinction coefficients for dyes used in three-compartment binding model, 78860A (11 February 2011); doi: 10.1117/12.875408
Proc. SPIE 7886, Combination of PI3K/Akt/mTOR inhibitors and PDT in endothelial and tumor cells, 78860B (11 February 2011); doi: 10.1117/12.876042
Proc. SPIE 7886, Signaling from lysosomes to mitochondria sensitizes cancer cells to photodynamic treatment, 78860C (18 February 2011); doi: 10.1117/12.878306
Preclinical PDT III
Proc. SPIE 7886, Folate receptor targeted Type 1 photosensitizer bioconjugates for tumor visualization and phototherapy, 78860D (8 February 2011); doi: 10.1117/12.875166
Proc. SPIE 7886, A dynamic model for ALA-PDT of skin: analysis of the correlation of fluorescence and singlet oxygen luminescence to spatial distribution of singlet oxygen, 78860F (8 February 2011); doi: 10.1117/12.874194
Proc. SPIE 7886, Photosensitizer nanocarriers modeling for photodynamic therapy applied to dermatological diseases, 78860G (11 February 2011); doi: 10.1117/12.875070
Clinical PDT I
Proc. SPIE 7886, Photodynamic therapy of pancreatic cancer and elastic scattering spectroscopy of the duodenal mucosa for the detection of pancreaticobiliary malignancy, 78860J (11 February 2011); doi: 10.1117/12.874053
Clinical PDT II
Proc. SPIE 7886, 5-Fluorouracil as an enhancer of aminolevulinate-based photodynamic therapy for skin cancer: New use for a venerable agent?, 78860K (11 February 2011); doi: 10.1117/12.874188
Proc. SPIE 7886, An IR navigation system for real-time treatment guidance of pleural PDT, 78860L (28 February 2011); doi: 10.1117/12.875635
Proc. SPIE 7886, Investigating the photosensitizer-potential of targeted gallium corrole using multimode optical imaging, 78860M (18 February 2011); doi: 10.1117/12.873337
PDT Models
Proc. SPIE 7886, Determining how uncertainties in optical properties affect light dose calculations for PDT, 78860N (11 February 2011); doi: 10.1117/12.875378
Proc. SPIE 7886, Modeling of PDT kinetics in cell killing, 78860O (11 February 2011); doi: 10.1117/12.875066
Proc. SPIE 7886, Study of the relationship between light fluence and photodynamic therapy in a homogeneous tissue phantom, 78860Q (11 February 2011); doi: 10.1117/12.874220
Animal Studies
Proc. SPIE 7886, Assessment of biophysical tumor response to PDT in pancreatic cancer using localized reflectance spectroscopy, 78860S (11 February 2011); doi: 10.1117/12.876147
Proc. SPIE 7886, In vitro photodynamic therapy of MG-63 osteosarcoma cells mediated by aminolevulinic acid, 78860T (11 February 2011); doi: 10.1117/12.876337
Proc. SPIE 7886, Study of photosensitizers pharmacokinetics in mouse tumor model by transillumination fluorescence imaging in vivo, 78860U (11 February 2011); doi: 10.1117/12.873870
Poster Session
Proc. SPIE 7886, EtNBS and EtNBS-COOH PDT efficacy in ovarian cancer cells, 78860W (28 February 2011); doi: 10.1117/12.877591
Proc. SPIE 7886, Effect of fatty acids on the complexation of proteins with porphyrins, 78860X (28 February 2011); doi: 10.1117/12.876255
Proc. SPIE 7886, Preparation, characterization, and cellular studies of photosensitizer-loaded lipid nanoparticles for photodynamic therapy, 78860Y (18 February 2011); doi: 10.1117/12.876125
Proc. SPIE 7886, In vivo validation of high frequency ultrasound-guided fluorescence tomography system to improve delivery of photodynamic therapy, 788610 (11 February 2011); doi: 10.1117/12.875629
Proc. SPIE 7886, MS2 bacteriophage as a delivery vessel of porphyrins for photodynamic therapy, 788614 (11 February 2011); doi: 10.1117/12.875202
Proc. SPIE 7886, Light distribution in turbid media: an approach based on matrices, 788615 (11 February 2011); doi: 10.1117/12.875163
Proc. SPIE 7886, Pheophorbide a mediated photodynamic therapy against human epidermoid carcinoma cells (A431), 788616 (11 February 2011); doi: 10.1117/12.874978
Proc. SPIE 7886, Mechanisms of tumor necrosis in photodynamic therapy with a chlorine photosensitizer: experimental studies, 788617 (18 February 2011); doi: 10.1117/12.874976
Proc. SPIE 7886, A study of light fluence rate distribution for PDT using MC simulation, 788619 (11 February 2011); doi: 10.1117/12.875389
Back to Top